- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 21.59M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$1.14M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.04M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $2.62M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $3.22M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $6.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.79M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $11.06M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.76M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $32.64M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $32.2M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $37.11M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $36.93M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 20.71M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $167.17K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $38.37M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $39.58M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.09M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $970.88K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.34M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.26M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $3.72M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $8.93M |
| Revenue | Q1 2025 · Mar 31, 2024 | $12.65M |